New study aims to crack the code on tough colorectal cancer
NCT ID NCT03699111
First seen Apr 26, 2026 · Last updated Jun 23, 2026 · Updated 6 times
Summary
This completed study looked at 29 people with a specific, hard-to-treat type of advanced colorectal cancer. The goal was not to test a new drug, but to find better ways to group patients based on the biology of their cancer. Researchers hope this will help doctors choose the right treatments for the right patients in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beaumont Hospital
Dublin, Ireland
-
Bon Secours Hospital, Cork
Cork, Ireland
-
Hospital Universitari Vall d'Hebron
Barcelona, Spain
-
Institut Catala d'Oncologia
Barcelona, Spain
-
Private Practice Oncology, Heidelberg
Heidelberg, Germany
-
Private Practice Oncology, Speyer
Speyer, Germany
-
St Vincent's University Hospital
Dublin, Ireland
-
Tallaght University Hospital
Dublin, Ireland
-
University Hospital Galway
Galway, Ireland
-
University Hospital, Mannheim
Mannheim, Germany
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to better ways to group patients with this type of colorectal cancer, potentially guiding more personalized treatment decisions in the future.
What could go wrong
This was a small, early-stage study focused on data analysis, not testing a treatment. The findings may not directly improve patient outcomes or be confirmed in larger studies.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.